| Dr Scott Naftulin, DO | |
|
5325 Northgate Dr Ste 209, Bethlehem, PA 18017-9416 | |
| (610) 954-9400 | |
| Not Available |
| Full Name | Dr Scott Naftulin |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 37 Years |
| Location | 5325 Northgate Dr Ste 209, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861485369 | NPI | - | NPPES |
| 1104348 | Other | PA | AMERIHEALTH |
| 0061374000 | Other | PA | KEYSTONE EAST |
| 050903 | Other | PA | BLUE CARE |
| 41608-1067 | Other | PA | GEISINGER |
| 462565 | Other | PA | AETNA |
| 807509 | Other | PA | BLUE CARE HMO (FPH) |
| 001501832-0004 | Medicaid | PA | |
| P00126483 | Other | PA | RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steffie Enterprises, Inc | 0840225736 | 354 |
| Northeastern Rehabilitation Associates, Pc | 5193714723 | 52 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it has exceeded 90% enrollment reaching 85 patients for its pivotal Phase III Metastatic Melanoma Trial.
As America grapples with reforming health care with an eye to introducing a public option, a new book published by the Fraser Institute, one of Canada's leading economic think tanks, details the failures of Canada's government-run health care system and serves as a warning to U.S. policy-makers.
In recent time, many epidemiological studies have proved very close links existing between diabetes and Alzheimer´s disease. In fact, it has been stated that diabetes is a significant risk factor for suffering from Alzheimer and vascular dementia, the two main causes of dementia.
News outlets sort through the players in this drama to find winners and losers - as well as how some lawmakers and advocates will move forward.
Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin, has now confirmed this hypothesis and identified the cells and mechanisms brought into play: the immune system cells macrophages, present in the epithelium of the urethra, allow the entry of HIV. This work, published online on the website of the journal Mucosal Immunology, could make it possible to test novel HIV/AIDS prevention strategies.
› Verified 2 days ago
| Entity Name | Northeastern Rehabilitation Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104878412 PECOS PAC ID: 5193714723 Enrollment ID: O20040510000579 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it has exceeded 90% enrollment reaching 85 patients for its pivotal Phase III Metastatic Melanoma Trial.
As America grapples with reforming health care with an eye to introducing a public option, a new book published by the Fraser Institute, one of Canada's leading economic think tanks, details the failures of Canada's government-run health care system and serves as a warning to U.S. policy-makers.
In recent time, many epidemiological studies have proved very close links existing between diabetes and Alzheimer´s disease. In fact, it has been stated that diabetes is a significant risk factor for suffering from Alzheimer and vascular dementia, the two main causes of dementia.
News outlets sort through the players in this drama to find winners and losers - as well as how some lawmakers and advocates will move forward.
Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin, has now confirmed this hypothesis and identified the cells and mechanisms brought into play: the immune system cells macrophages, present in the epithelium of the urethra, allow the entry of HIV. This work, published online on the website of the journal Mucosal Immunology, could make it possible to test novel HIV/AIDS prevention strategies.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Naftulin, DO 5 Morgan Hwy, Suite 4, Scranton, PA 18508-2641 Ph: (570) 344-3788 | Dr Scott Naftulin, DO 5325 Northgate Dr Ste 209, Bethlehem, PA 18017-9416 Ph: (610) 954-9400 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it has exceeded 90% enrollment reaching 85 patients for its pivotal Phase III Metastatic Melanoma Trial.
As America grapples with reforming health care with an eye to introducing a public option, a new book published by the Fraser Institute, one of Canada's leading economic think tanks, details the failures of Canada's government-run health care system and serves as a warning to U.S. policy-makers.
In recent time, many epidemiological studies have proved very close links existing between diabetes and Alzheimer´s disease. In fact, it has been stated that diabetes is a significant risk factor for suffering from Alzheimer and vascular dementia, the two main causes of dementia.
News outlets sort through the players in this drama to find winners and losers - as well as how some lawmakers and advocates will move forward.
Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin, has now confirmed this hypothesis and identified the cells and mechanisms brought into play: the immune system cells macrophages, present in the epithelium of the urethra, allow the entry of HIV. This work, published online on the website of the journal Mucosal Immunology, could make it possible to test novel HIV/AIDS prevention strategies.
› Verified 2 days ago